Jeffrey R. Harder is Director at REPROS THERAPEUTICS INC. (RPRX). They have made 9 open-market trades across 1 company since 2006, most recently 2008-11-18.
CIK 0001331042
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
9 open-market purchases totalling $72K since 2006, never a sale. Across 9 scored buys the stock is up 1.1% at ninety days, and 0.9 points ahead of the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RPRX | 400 | $24K |
Shares reported on the most recent Form 4, priced at the 2008-11-19 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | +18.4% | +1.1% | +1.1% |
| Alpha | -34.8% | +0.9% | +0.9% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RPRX | BUY | 2008-11-18 | 2008-11-19 | $9.79 | $4K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2008-10-22 | 2008-10-22 | $6.47 | $13K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2008-05-23 | 2008-05-23 | $9.14 | $9K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2008-04-15 | 2008-04-15 | $8.51 | $9K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2008-03-03 | 2008-03-03 | $8.54 | $4K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2008-02-26 | 2008-02-26 | $8.80 | $4K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2008-01-24 | 2008-01-28 | $8.90 | $9K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2006-12-01 | 2006-12-04 | $5.89 | $12K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2006-07-06 | 2006-07-07 | $7.95 | $8K | +18.4% | +1.1% | +1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.